4Filing Date: Aug 24, 2026
Core Scientific (CORZ)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000905148-26-003881
Total Value$110.0K
Trades1
Insiders1
Transaction Details
CRAIN ELIZABETH
Director·Direct
Buy · Acquire
Common Stock
Shares+6.00K
Price$18.33
Total Value$110.0K
Shares Owned After71.35K
Transaction DateAug 20, 2026
Footnotes ▸
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.27 to $18.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
Post-Transaction Holdings
CRAIN ELIZABETH · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 71.35K | +6.00K (9.18%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-08-20
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Core Scientific, Inc./tx (CORZ)
CIK: 0001839341
--- Reporting Owner ---
Name: CRAIN ELIZABETH
CIK: 0001604659
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-08-20 | Code: P (Open market purchase)
Shares: +6,000 | Price: $18.33
Total Value: $109,994.40
Shares Owned After: 71,348 | Ownership: D (Direct)
Footnotes:
[F1] The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.27 to $18.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
--- Footnotes (Complete Index) ---
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.27 to $18.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
--- Signature ---
/s/ /s/ Todd DuChene, as Attorney-in-Fact (2026-08-24)